Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 203

1.

Alternate nucleic acid targets can be used to create a composite standard to evaluate clinical performance of nucleic acid amplification tests.

Schachter J, Chernesky M.

J Clin Microbiol. 2019 May 29. pii: JCM.00661-19. doi: 10.1128/JCM.00661-19. [Epub ahead of print]

PMID:
31142606
2.

Treatment of first-void urine with Aptima Transfer Solution increases detection of high-risk HPV E6/E7 mRNA.

Arias M, Jang D, Dockter J, Ratnam S, Shah A, Elit L, Smieja M, Lytwyn A, Getman D, Weinbaum B, Chernesky M.

J Virol Methods. 2019 May;267:48-52. doi: 10.1016/j.jviromet.2019.02.007. Epub 2019 Feb 21.

PMID:
30797768
3.

Comparative performance of human papillomavirus messenger RNA versus DNA screening tests at baseline and 48 months in the HPV FOCAL trial.

Cook DA, Smith LW, Law JH, Mei W, Gondara L, van Niekerk DJ, Ceballos KM, Jang D, Chernesky M, Franco EL, Ogilvie GS, Coldman AJ, Krajden M.

J Clin Virol. 2018 Nov;108:32-37. doi: 10.1016/j.jcv.2018.09.004. Epub 2018 Sep 10.

PMID:
30223252
4.

HPV E6 oncoproteins and nucleic acids in neck lymph node fine needle aspirates and oral samples from patients with oropharyngeal squamous cell carcinoma.

Chernesky M, Jang D, Schweizer J, Arias M, Doerwald-Munoz L, Gupta M, Jackson B, Archibald S, Young J, Lytwyn A, Smieja M, Severini A, Ecobichon-Morris A, Hyrcza M.

Papillomavirus Res. 2018 Dec;6:1-5. doi: 10.1016/j.pvr.2018.05.003. Epub 2018 May 26.

5.

Trichomonas vaginalis Prevalence and Correlates in Women and Men Attending STI Clinics in Western Canada.

Gratrix J, Plitt S, Turnbull L, Smyczek P, Brandley J, Scarrott R, Naidu P, Bertholet L, Chernesky M, Read R, Singh AE.

Sex Transm Dis. 2017 Oct;44(10):627-629. doi: 10.1097/OLQ.0000000000000650.

PMID:
28876319
6.

Detection of cervical precancerous lesions with Aptima HPV assays using SurePath preservative fluid specimens.

Chernesky M, Jang D, Escott N, Gilchrist J, Li J, Elit L, Lytwyn A, Smieja M, Ratnam S, Arias M, Getman D, Weinbaum B, Kirkconnell B, Dockter J.

Papillomavirus Res. 2017 Jun;3:155-159. doi: 10.1016/j.pvr.2017.04.005. Epub 2017 Apr 28.

7.

Urinary Meatal Swabbing Detects More Men Infected With Mycoplasma genitalium and Four Other Sexually Transmitted Infections Than First Catch Urine.

Chernesky M, Jang D, Smieja M, Arias M, Martin I, Weinbaum B, Getman D.

Sex Transm Dis. 2017 Aug;44(8):489-491. doi: 10.1097/OLQ.0000000000000618.

PMID:
28703728
8.

Prevalence and antibiotic resistance of Mycoplasma genitalium among STI clinic attendees in Western Canada: a cross-sectional analysis.

Gratrix J, Plitt S, Turnbull L, Smyczek P, Brandley J, Scarrott R, Naidu P, Parker P, Blore B, Bull A, Shokoples S, Bertholet L, Martin I, Chernesky M, Read R, Singh A.

BMJ Open. 2017 Jul 10;7(7):e016300. doi: 10.1136/bmjopen-2017-016300.

9.

Mycoplasma genitalium Antibiotic Resistance-Mediating Mutations in Canadian Women With or Without Chlamydia Trachomatis Infection.

Chernesky MA, Jang D, Martin I, Hoang LMN, Naidu P, Levett PN, Wylie J, Rebbapragada A, Ratnam S, Smieja M, Weinbaum B, Getman D; Canadian MG Study Group.

Sex Transm Dis. 2017 Jul;44(7):433-435. doi: 10.1097/OLQ.0000000000000617.

PMID:
28608794
10.

Developing a new diagnostic algorithm for human papilloma virus associated oropharyngeal carcinoma: an investigation of HPV DNA assays.

Cohen N, Gupta M, Doerwald-Munoz L, Jang D, Young JE, Archibald S, Jackson B, Lee J, Chernesky M.

J Otolaryngol Head Neck Surg. 2017 Feb 13;46(1):11. doi: 10.1186/s40463-017-0189-z.

11.

Comparison of cobas 4800, m2000, Viper XTR, and Infinity 80 Automated Instruments When Processing Urine Specimens for the Diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae.

Chernesky MA, Jang D, Gilchrist J, Smieja M, Arias M, Hatchette T, Poirier A, Mayne D, Ratnam S.

Sex Transm Dis. 2017 Mar;44(3):161-165. doi: 10.1097/OLQ.0000000000000570.

PMID:
28182591
12.

Aptima HPV Assay versus Hybrid Capture® 2 HPV test for primary cervical cancer screening in the HPV FOCAL trial.

Cook DA, Smith LW, Law J, Mei W, van Niekerk DJ, Ceballos K, Gondara L, Franco EL, Coldman AJ, Ogilvie GS, Jang D, Chernesky M, Krajden M.

J Clin Virol. 2017 Feb;87:23-29. doi: 10.1016/j.jcv.2016.12.004. Epub 2016 Dec 11.

13.

Comparison of Workflow, Maintenance, and Consumables in the GeneXpert Infinity 80 and Panther Instruments While Testing for Chlamydia trachomatis and Neisseria gonorrhoeae.

Jang D, Ratnam S, Gilchrist J, Arias M, Smieja M, Mayne D, Chernesky MA.

Sex Transm Dis. 2016 Jun;43(6):377-81. doi: 10.1097/OLQ.0000000000000444.

PMID:
27196259
14.

Rapid Diagnosis of Trichomonas vaginalis by Testing Vaginal Swabs in an Isothermal Helicase-Dependent AmpliVue Assay.

Gaydos CA, Hobbs M, Marrazzo J, Schwebke J, Coleman JS, Masek B, Dize L, Jang D, Li J, Chernesky M.

Sex Transm Dis. 2016 Jun;43(6):369-73. doi: 10.1097/OLQ.0000000000000447.

15.

Ease, Comfort, and Performance of the HerSwab Vaginal Self-Sampling Device for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae.

Arias M, Jang D, Gilchrist J, Luinstra K, Li J, Smieja M, Chernesky MA.

Sex Transm Dis. 2016 Feb;43(2):125-9. doi: 10.1097/OLQ.0000000000000406.

PMID:
26760183
16.

Canadian Public Health Laboratory Network national syphilis laboratory testing recommendations: INTRODUCTION.

Members of the Canadian Public Health Laboratory Network Syphilis Laboratory Task Group during authorship (co-chairs and membership in alphabetical order), Tsang RS, Morshed M, Allen V, Chernesky MA, Fonseca K, Garceau R, Jayaraman GC, Kadkhoda K, Lee BE, Levett PN, Radons SM, Serhir B, Singh AE, Wong T.

Can J Infect Dis Med Microbiol. 2015 Jan-Feb;26 Suppl A:4A-5A. No abstract available.

17.

Canadian Public Health Laboratory Network laboratory guidelines for the use of point-of-care tests for the diagnosis of syphilis in Canada.

Singh AE, Chernesky MA, Morshed M, Wong T.

Can J Infect Dis Med Microbiol. 2015 Jan-Feb;26 Suppl A:29A-32A.

18.

Canadian Public Health Laboratory Network laboratory guidelines for the diagnosis of neurosyphilis in Canada.

Wong T, Fonseca K, Chernesky MA, Garceau R, Levett PN, Serhir B.

Can J Infect Dis Med Microbiol. 2015 Jan-Feb;26 Suppl A:18A-22A.

19.

Canadian Public Health Laboratory Network laboratory guidelines for the use of direct tests to detect syphilis in Canada.

Tsang RS, Morshed M, Chernesky MA, Jayaraman GC, Kadkhoda K.

Can J Infect Dis Med Microbiol. 2015 Jan-Feb;26 Suppl A:13A-7A.

20.

Comparison of flocked and aptima swabs and two specimen transport media in the aptima combo 2 assay.

Li J, Jang D, Gilchrist J, Smieja M, Ewert R, MacRitchie C, Chernesky M.

J Clin Microbiol. 2014 Oct;52(10):3808-9. doi: 10.1128/JCM.01614-14. Epub 2014 Aug 13.

21.

Evaluation of a new APTIMA specimen collection and transportation kit for high-risk human papillomavirus E6/E7 messenger RNA in cervical and vaginal samples.

Chernesky M, Jang D, Gilchrist J, Elit L, Lytwyn A, Smieja M, Dockter J, Getman D, Reid J, Hill C.

Sex Transm Dis. 2014 Jun;41(6):365-8. doi: 10.1097/OLQ.0000000000000125.

PMID:
24825332
22.

Workflow and maintenance characteristics of five automated laboratory instruments for the diagnosis of sexually transmitted infections.

Ratnam S, Jang D, Gilchrist J, Smieja M, Poirier A, Hatchette T, Flandin JF, Chernesky M.

J Clin Microbiol. 2014 Jul;52(7):2299-304. doi: 10.1128/JCM.03549-13. Epub 2014 Apr 16.

23.

Head-to-head comparison of second-generation nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae on urine samples from female subjects and self-collected vaginal swabs.

Chernesky M, Jang D, Gilchrist J, Hatchette T, Poirier A, Flandin JF, Smieja M, Ratnam S.

J Clin Microbiol. 2014 Jul;52(7):2305-10. doi: 10.1128/JCM.03552-13. Epub 2014 Apr 2.

24.

Ease and comfort of cervical and vaginal sampling for Chlamydia trachomatis and Trichomonas vaginalis with a new Aptima specimen collection and transportation kit.

Chernesky M, Jang D, Gilchrist J, Randazzo J, Elit L, Lytwyn A, Smieja M, Reid J, Hill C.

J Clin Microbiol. 2014 Feb;52(2):668-70. doi: 10.1128/JCM.02923-13. Epub 2013 Dec 4.

25.

Self-collected swabs of the urinary meatus diagnose more Chlamydia trachomatis and Neisseria gonorrhoeae infections than first catch urine from men.

Chernesky MA, Jang D, Portillo E, Smieja M, Gilchrist J, Ewert R, Macritchie C.

Sex Transm Infect. 2013 Mar;89(2):102-4. doi: 10.1136/sextrans-2012-050573. Epub 2012 Sep 28.

PMID:
23024224
26.

Comparison of three assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in SurePath Pap samples and the role of pre- and postcytology testing.

Chernesky M, Jang D, Portillo E, Smieja M, Kapala J, Doucette C, Sumner J, Ewert R, MacRitchie C, Gilchrist J.

J Clin Microbiol. 2012 Apr;50(4):1281-4. doi: 10.1128/JCM.06595-11. Epub 2012 Jan 18.

27.

Routine confirmation of positive nucleic acid amplification test results for Neisseria gonorrhoeae is not necessary.

Schachter J, Chernesky MA.

J Clin Microbiol. 2012 Jan;50(1):208; author reply 209-10. doi: 10.1128/JCM.06004-11. No abstract available.

28.

Performance of a New HPV Cervi-Collect Collection and Transportation Kit.

Chernesky M, Huang S, Jang D, Erickson B, Salituro J, Engel H, Gilchrist J, Neuscheler P, Mak WB, Abravaya K.

J Oncol. 2012;2012:503432. doi: 10.1155/2012/503432. Epub 2011 Nov 14.

29.

Comparison of dacron and nylon-flocked self-collected vaginal swabs and urine for the detection of Trichomonas vaginalis using analyte-specific reagents in a transcription-mediated amplification assay.

Jang D, Gilchrist J, Portillo E, Smieja M, Toor R, Chernesky M.

Sex Transm Infect. 2012 Apr;88(3):160-2. doi: 10.1136/sextrans-2011-050084. Epub 2011 Dec 13.

PMID:
22166474
30.

Aptima Combo 2 testing detected additional cases of Neisseria gonorrhoeae infection in men and women in community settings.

Kapala J, Biers K, Cox M, Kamionka M, Sumner J, Toor R, Gilchrist J, Jang D, Smieja M, Chernesky M.

J Clin Microbiol. 2011 May;49(5):1970-1. doi: 10.1128/JCM.02062-10. Epub 2011 Mar 16.

31.

Comparative evaluation of AMPLICOR HPV PCR and Linear Array assays on SurePath liquid-based Pap samples for the detection of high-risk HPV genotypes.

Chernesky M, Jang D, Portillo E, Smieja M, Chong S, Buracond S, Klingel M, El Sebai R, Kapala J, Patel J, Biers K, Harroun N, Doucette C, Sumner J.

J Clin Virol. 2011 Mar;50(3):201-4. doi: 10.1016/j.jcv.2010.12.003. Epub 2010 Dec 30.

PMID:
21195020
32.

Development and evaluation of a flocked nasal midturbinate swab for self-collection in respiratory virus infection diagnostic testing.

Smieja M, Castriciano S, Carruthers S, So G, Chong S, Luinstra K, Mahony JB, Petrich A, Chernesky M, Savarese M, Triva D.

J Clin Microbiol. 2010 Sep;48(9):3340-2. doi: 10.1128/JCM.02235-09. Epub 2010 Jul 7.

33.

Detection of high risk HPV and Chlamydia trachomatis in vaginal and cervical samples collected with flocked nylon and wrapped rayon dual swabs transported in dry tubes.

Krech T, Castriciano S, Jang D, Smieja M, Enders G, Chernesky M.

J Virol Methods. 2009 Dec;162(1-2):291-3. doi: 10.1016/j.jviromet.2009.08.011. Epub 2009 Aug 22.

PMID:
19703493
34.

Validation of the APTIMA Combo 2 assay for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in SurePath liquid-based pap test samples taken with different collection devices.

Chernesky M, Jang D, Smieja M, Portillo E, Ewert R, Pritchard C, MacEachern D, Doucette C, MacDonald A, Kapala J, Sumner J, Hill C.

Sex Transm Dis. 2009 Sep;36(9):581-3. doi: 10.1097/OLQ.0b013e3181a4c3fc.

PMID:
19661842
35.

The limitations of point of care testing for pandemic influenza: what clinicians and public health professionals need to know.

Hatchette TF, Bastien N, Berry J, Booth TF, Chernesky M, Couillard M, Drews S, Ebsworth A, Fearon M, Fonseca K, Fox J, Gagnon JN, Guercio S, Horsman G, Jorowski C, Kuschak T, Li Y, Majury A, Petric M, Ratnam S, Smieja M, Van Caeseele P; Pandemic Influenza Laboratory Preparedness Network.

Can J Public Health. 2009 May-Jun;100(3):204-7.

PMID:
19507723
36.

The evaluation of diagnostic tests for sexually transmitted infections.

Chernesky MA.

Can J Infect Dis Med Microbiol. 2005 Mar;16(2):80-2.

37.

The laboratory diagnosis of Chlamydia trachomatis infections.

Chernesky MA.

Can J Infect Dis Med Microbiol. 2005 Jan;16(1):39-44.

38.

Syndromes associated with sexually transmitted infections.

Chernesky MA, Patrick D.

Can J Infect Dis Med Microbiol. 2005 Jan;16(1):13-4. No abstract available.

39.

Detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in North American women by testing SurePath liquid-based Pap specimens in APTIMA assays.

Chernesky M, Freund GG, Hook E 3rd, Leone P, D'Ascoli P, Martens M.

J Clin Microbiol. 2007 Aug;45(8):2434-8. Epub 2007 Jun 20.

40.

Abilities of APTIMA, AMPLICOR, and ProbeTec assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in PreservCyt ThinPrep Liquid-based Pap samples.

Chernesky M, Jang D, Portillo E, Chong S, Smieja M, Luinstra K, Petrich A, Macritchie C, Ewert R, Hayhoe B, Sarabia A, Thompson F.

J Clin Microbiol. 2007 Aug;45(8):2355-8. Epub 2007 May 30.

41.

Pap cytopathology and the presence of high-risk human papillomavirus in SurePath liquid preservative and Digene cervical sampler specimens.

Kapala J, Jang D, Patel J, Biers K, Smieja M, Chernesky M.

J Virol Methods. 2007 Jun;142(1-2):223-5. Epub 2007 Feb 23.

PMID:
17320978
42.

Comparison of the RIDASCREEN norovirus enzyme immunoassay to IDEIA NLV GI/GII by testing stools also assayed by RT-PCR and electron microscopy.

Castriciano S, Luinstra K, Petrich A, Smieja M, Lee C, Jang D, Portillo E, Chernesky M.

J Virol Methods. 2007 May;141(2):216-9. Epub 2007 Jan 8.

PMID:
17208311
43.

Characteristics of the m2000 automated sample preparation and multiplex real-time PCR system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.

Marshall R, Chernesky M, Jang D, Hook EW, Cartwright CP, Howell-Adams B, Ho S, Welk J, Lai-Zhang J, Brashear J, Diedrich B, Otis K, Webb E, Robinson J, Yu H.

J Clin Microbiol. 2007 Mar;45(3):747-51. Epub 2007 Jan 3.

44.

Multicenter comparison of nucleic acid extraction methods for detection of severe acute respiratory syndrome coronavirus RNA in stool specimens.

Petrich A, Mahony J, Chong S, Broukhanski G, Gharabaghi F, Johnson G, Louie L, Luinstra K, Willey B, Akhaven P, Chui L, Jamieson F, Louie M, Mazzulli T, Tellier R, Smieja M, Cai W, Chernesky M, Richardson SE; Ontario Laboratory Working Group for the Rapid Diagnosis of Emerging Infections.

J Clin Microbiol. 2006 Aug;44(8):2681-8.

45.

APTIMA transcription-mediated amplification assays for Chlamydia trachomatis and Neisseria gonorrhoeae.

Chernesky MA, Jang DE.

Expert Rev Mol Diagn. 2006 Jul;6(4):519-25. Review.

PMID:
16824026
46.
47.
48.

High analytical sensitivity and low rates of inhibition may contribute to detection of Chlamydia trachomatis in significantly more women by the APTIMA Combo 2 assay.

Chernesky M, Jang D, Luinstra K, Chong S, Smieja M, Cai W, Hayhoe B, Portillo E, Macritchie C, Main C, Ewert R.

J Clin Microbiol. 2006 Feb;44(2):400-5.

49.

Women find it easy and prefer to collect their own vaginal swabs to diagnose Chlamydia trachomatis or Neisseria gonorrhoeae infections.

Chernesky MA, Hook EW 3rd, Martin DH, Lane J, Johnson R, Jordan JA, Fuller D, Willis DE, Fine PM, Janda WM, Schachter J.

Sex Transm Dis. 2005 Dec;32(12):729-33.

PMID:
16314768
50.

Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections.

Schachter J, Chernesky MA, Willis DE, Fine PM, Martin DH, Fuller D, Jordan JA, Janda W, Hook EW 3rd.

Sex Transm Dis. 2005 Dec;32(12):725-8.

PMID:
16314767

Supplemental Content

Loading ...
Support Center